P4A experts regularly share their unique perspectives that inform and challenge the norm through articles and white papers.
EU Market Access 2021: What’s in Store for Orphan Drugs and ATMPs?
What are the key considerations for manufacturers to optimise their market access strategy and implementation plans? Find out here. @Partners4A
#OrphanDrugs #Manufacturing #EU #Market
Please support #P4A in our 7k fundraising run for @rarediseaseuk We would love for you to donate and also take part and send us your training videos! #NewYear #fitness
I'm fundraising for Genetic Alliance UK - Rare Disease UK. Check out my @JustGiving page and please donate if you can. Thank you! #JustGiving https://www.justgiving.com/fundraising/raredisease?utm_source=Twitter&utm_medium=fundraising&utm_content=raredisease&utm_campaign=pfp-tweet&utm_term=37c2c193d2e84fc9a731947a15eb29c8
What does the future look like for a child recently diagnosed with a rare disease and his/her parents? 🤔
📘 You may find the answers to some of your questions in this booklet.